The drug pricing debate rages on, particularly within oncology. I led a panel on Promising Drugs, Pricing and Access at MedCity Converge on July 9th. Good summary is here. Our panelists were awesome!
- Patrick Davish, AVP, Global & US Pricing/Market Access, Merck
- Robert Dubois M.D., Chief Science Officer and Executive Vice President, National Pharmaceutical Council
- Gary Kurtzman, M.D., Senior Vice President and Managing Director, Healthcare, Safeguard Scientific
- Steven Lucio, Associate Vice President, Pharmacy Services, Vizient